Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wilczynski

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Gynecologic Oncology|May 1, 1995
UCI-VULV-1, a vulvar squamous carcinoma cell lineP M Carpenter, G Gamboa-Vujicic, J T Mascarello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positiveL Muderspach, S Wilczynski, L Roman, et al.
Cell and Tissue Research|April 18, 1998
Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumorsS L Li, H Goko, Z D Xu, et al.
British Journal of Cancer|April 22, 2015
A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomasZ Eroglu, H A Tawbi, J Hu, et al.
Gynecologic Oncology|September 10, 1999
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group studyE A Poplin, P Y Liu, J E Delmore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignanciesWong JYC, D Z Chu, D M Yamauchi, et al.
International Journal of Oncology|April 30, 2011
Mutational analysis of the hMSH2 gene in a wide variety of tumorsY Hatta, M Wada, S Takeuchi, et al.
Gynecologic Oncology|July 17, 2007
A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasiaL D Roman, S Wilczynski, L I Muderspach, et al.
Gynecologic Oncology|September 5, 2001
Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326)M L Rothenberg, P Y Liu, S Wilczynski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancerJ Y Wong, G Somlo, T Odom-Maryon, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Gynecologic Oncology|May 1, 1995
UCI-VULV-1, a vulvar squamous carcinoma cell lineP M Carpenter, G Gamboa-Vujicic, J T Mascarello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positiveL Muderspach, S Wilczynski, L Roman, et al.
Cell and Tissue Research|April 18, 1998
Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumorsS L Li, H Goko, Z D Xu, et al.
British Journal of Cancer|April 22, 2015
A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomasZ Eroglu, H A Tawbi, J Hu, et al.
Gynecologic Oncology|September 10, 1999
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group studyE A Poplin, P Y Liu, J E Delmore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignanciesWong JYC, D Z Chu, D M Yamauchi, et al.
International Journal of Oncology|April 30, 2011
Mutational analysis of the hMSH2 gene in a wide variety of tumorsY Hatta, M Wada, S Takeuchi, et al.
Gynecologic Oncology|July 17, 2007
A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasiaL D Roman, S Wilczynski, L I Muderspach, et al.
Gynecologic Oncology|September 5, 2001
Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326)M L Rothenberg, P Y Liu, S Wilczynski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancerJ Y Wong, G Somlo, T Odom-Maryon, et al.
Pageof 3